Rosemary Cummins, is a rated equity research analyst with 20 experience specialising in Healthcare research at Citigroup and UBS; together with a focus on global plasma products. She has been a consultant to several Australian and international companies and has also led the Investor Relations function for ASX100 listed pharmacy distribution and hospital companies.
